Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan W Cummins

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|August 31, 2010
Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individualsStacey A Rizza, Nathan W Cummins, David N Rider, et al.
Plos One|February 13, 2016
Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?Jasmine R Marcelin, Melody L Berg, Eugene M Tan, et al.
Journal of Virology|November 30, 2022
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse ModelAswath P Chandrasekar, Nathan W Cummins, Sekar Natesampillai, et al.
BMJ Open|March 19, 2021
Association of outpatient ACE inhibitors and angiotensin receptor blockers and outcomes of acute respiratory illness: a retrospective cohort studyMolly Moore Jeffery, Nathan W Cummins, Timothy M Dempsey, et al.
Plos Pathogens|December 3, 2010
Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cellsSekar Natesampillai, Zilin Nie, Nathan W Cummins, et al.
Mayo Clinic Proceedings|May 14, 2020
COVID-19 Ethics and ResearchKaren M Meagher, Nathan W Cummins, Adil E Bharucha, et al.
Open Forum Infectious Diseases|June 7, 2017
<i>Lysinibacillus massiliensis</i> Panniculitis Masquerading as Erythema Nodosum: A Case ReportJay J Jin, Phillip J Keith, Nathan W Cummins, et al.
Mayo Clinic Proceedings|February 7, 2021
COVID-19: Understanding Inter-Individual Variability and Implications for Precision MedicineNaveen L Pereira, Ferhaan Ahmad, Mirnela Byku, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2019
Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV InfectionShukaib Arslan, Mark R Litzow, Nathan W Cummins, et al.
Plos One|September 21, 2011
Human immunodeficiency virus envelope protein Gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrationsNathan W Cummins, Anna Klicpera, Amy M Sainski, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|August 31, 2010
Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individualsStacey A Rizza, Nathan W Cummins, David N Rider, et al.
Plos One|February 13, 2016
Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?Jasmine R Marcelin, Melody L Berg, Eugene M Tan, et al.
Journal of Virology|November 30, 2022
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse ModelAswath P Chandrasekar, Nathan W Cummins, Sekar Natesampillai, et al.
BMJ Open|March 19, 2021
Association of outpatient ACE inhibitors and angiotensin receptor blockers and outcomes of acute respiratory illness: a retrospective cohort studyMolly Moore Jeffery, Nathan W Cummins, Timothy M Dempsey, et al.
Plos Pathogens|December 3, 2010
Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cellsSekar Natesampillai, Zilin Nie, Nathan W Cummins, et al.
Mayo Clinic Proceedings|May 14, 2020
COVID-19 Ethics and ResearchKaren M Meagher, Nathan W Cummins, Adil E Bharucha, et al.
Open Forum Infectious Diseases|June 7, 2017
<i>Lysinibacillus massiliensis</i> Panniculitis Masquerading as Erythema Nodosum: A Case ReportJay J Jin, Phillip J Keith, Nathan W Cummins, et al.
Mayo Clinic Proceedings|February 7, 2021
COVID-19: Understanding Inter-Individual Variability and Implications for Precision MedicineNaveen L Pereira, Ferhaan Ahmad, Mirnela Byku, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2019
Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV InfectionShukaib Arslan, Mark R Litzow, Nathan W Cummins, et al.
Plos One|September 21, 2011
Human immunodeficiency virus envelope protein Gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrationsNathan W Cummins, Anna Klicpera, Amy M Sainski, et al.
Pageof 7